View in EDS

Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: The United Kingdom Named Patient Programme.

Saved in:
Bibliographic Details
Title: Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: The United Kingdom Named Patient Programme.
Authors: Khan, F.1, Ottensmeier, C.2, Popat, S.3, Dua, D.4, Dorey, N.5, Ellis, S.6, Szabo, M.2, Upadhyay, S.7, Califano, R.8, Chan, S.9, Lee, L.8, Ali, C.W.10, Nicolson, M.11, Bates, A.T.2, Button, M.12, Chaudhuri, A.13, Mulvenna, P.14, Shaw, H.M.15, Danson, S.J.1 s.danson@sheffield.ac.uk
Source: European Journal of Cancer. Jul2014, Vol. 50 Issue 10, p1717-1721. 5p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2014.03.001